Alphatec Spine
Medical Devices
Carlsbad, California

Overall Rank: 38
Category: Medical Devices
Category Rank: 7


  • Top HealthTech Company of 2023


ATEC is more than a medical technology company. They are an Organic Innovation Machine™ that is focused on Revolutionizing the Approach to Spine Surgery. They are committed to creating clinical distinction by developing new approaches to treat the various pathologies to ultimately achieve the goals of spine surgery. Their ultimate vision is to become The Standard-Bearer in Spine.


Become a Premium Subscriber

Please purchase a premium subscription to continue reading this report.

Subscribe Now

Key Products

EOSedge™ captures simultaneous, full-body frontal and lateral images of the patient in a functional standing position – enabling a true, global assessment of all alignment factors.

spineEOS is a 3D surgical planning tool designed to provide a deeper understanding of the patient’s alignment and deformity.

3D Reconstructions

EOS 3DServices works as an extension of a clinical practice, transforming EOS images into 3D reconstructions. Images are transmitted to the 3DServices team using a secure data connection. Highly specialized radiology technologists deliver accurate and on-time 3D measurements.

Key Executives

Patrick S. Miles, Chairman And Chief Executive Officer

Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Todd Koning, Chief Financial Officer

Todd Koning has served as Executive Vice President and Chief Financial Officer since April 2021. He brings over 20 years of focused medical device finance, accounting, and international experience. His ATEC appointment follows three years with Masimo Corporation, where he most recently served as Senior Vice President of Finance and Chief Accounting Officer, responsible for corporate planning and analysis, global accounting, SEC reporting, financial systems, and investor outreach. Prior to his role at Masimo, Todd served as Vice President of Finance at NuVasive, Inc. and Vice President of Finance at Ellipse Technologies, Inc., which was acquired by NuVasive in 2016. He also held various domestic and international finance and accounting leadership roles at Boston Scientific Corporation and Guidant Corporation. Todd holds an M.B.A. from Purdue University and a B.S. in Engineering from Michigan State University.

Brian Snider, Executive Vice President, Marketing

Brian Snider has served as Executive Vice President, Marketing since March 2017. Prior to joining Alphatec Spine, Brian held various marketing leadership and global product management roles within NuVasive, Inc. from 2008 to 2017. He most recently served as the Business Lead of Thoracolumbar Anterior, which included overall responsibility for the anterior column business including XLIF®. Prior to NuVasive, Brian held marketing leadership roles for Alveolus, Inc., a medical device company focused on interventional stent technologies. He started his career at KPMG Consulting in various business units including Life Sciences. Brian received an MBA from the Fuqua School of Business at Duke University and a BBA in Marketing and Information Systems from The George Washington University.

Eric Dasso, Executive Vice President, Adjunctive Technologies

Eric Dasso has served as Executive Vice President, Adjunctive Technologies since August 2019. Prior to joining the Company, Mr. Dasso held various marketing leadership and global product management roles within NuVasive, Inc. from 2001 to 2018. He most recently served as NuVasive’s Vice President, Global Implant Systems (February 2015 to June 2018), which included overall responsibility for that company’s product development, commercialization and marketing functions of its $750M global implant franchise. Prior to leading Global Implant Systems, Mr. Dasso over saw the marketing and development of NuVasive’s thoracolumbar portfolio in various roles of increasing responsibility from February 2005 to February 2015, including as Project Manager, Thoracolumbar Fixation (February 2005 to July 2007), Senior Project Manager, Thoracolumbar Fixation (July 2007 to September 2008), Director, Marketing, Thoracolumbar Fixation (September 2008 to June 2010), Senior Director, Thoracolumbar (June 2010 to January 2014) and as Vice President, Thoracolumbar Posterior (January 2014 to February 2015). Prior to Nuvasive, Mr. Dasso held various positions at Johnson and Johnson and Acxiom Inc. Mr. Dasso received a bachelor’s degree in Business Administration from California Polytechnic State University—San Luis Obispo.

KELLI HOWELL, Executive Vice President, Clinical Strategies

Kelli Howell has served as Executive Vice President, Clinical Strategies since March 2018. For the 18 years prior to joining us, she held various management positions at NuVasive, Inc., including Vice President, Research & Health Informatics from January 2017 to March 2018, Vice President, Research & Education of NuVasive, Inc. from February 2015 to January 2017, and Vice President, Research at NuVasive, Inc. from April 2012 to February 2015. Prior to joining NuVasive, Inc., Ms. Howell was involved in research at Orthopedic Biomechanics Laboratory (OBL), Beth Israel Deaconess Medical Center in Boston. Ms. Howell received a M.S. degree in Biomedical Engineering from Boston University and a B.A. degree in Engineering Sciences from Dartmouth College.

Dave Sponsel, Executive Vice President, Sales

Dave Sponsel has served as Executive Vice President, Sales since April 2019. Dave began his career at Alphatec Spine as Area Vice President, Sales, South in May 2018. Prior to joining Alphatec Spine, he held the position of General Manager, Spine Division for Medacta, USA, where he was responsible for sales, marketing, product management and product development. Prior to that, he had an exceedingly successful 11-year experience in sales and sales leadership with Stryker Spine, where he was recognized as Sales Director of the Year in 2014. Dave received a BS from Indiana State University in Business Management.

Customer insights

“EOS gives us reliable measurements to assess how much lordosis each patient needs for optimal alignment, which also reduces the stress on remaining levels in the spine to avoid adjacent segment disease.” -Paul Glazer, MD, Orthopedic Spine Surgeon, Spine Specialists of Boston


“It is now recognized that measurement of the Cobb angle based on a 2D image is insufficient for the assessment of AIS: EOS has revolutionized the assessment of AIS.” – Smith, JS, Haffrey, CJ, Bess, S., et al.

Company insights

“ATEC is focused on developing new standards for spine surgery regardless of surgical approach. With so much variation in spine surgery today, there is a great opportunity for ATEC to deliver new approaches that achieve the goals of surgery –decompression, stabilization, and alignment.” – Luiz Pimenta MD, PhD, Chief Medical Officer